News & Announcements
Accelerate@Babraham programme culminates in final pitching event
04 August 2023
The cohort of 2023 present findings and next steps to an invited audience at the Babraham Research Campus.
Latest Accelerate@Babraham cohort take their places on campus
26 May 2023
Babraham Research Campus has welcomed six new ventures to its Accelerate@Babraham 2023 programme.
Accelerate@Babraham 2023 Cohort Revealed
16 May 2023
Accelerate@Babraham, the Babraham Research Campus’ programme supporting early-stage life science ventures, announces new cohort
Mosaic Therapeutics closes $28m Series A funding round
06 April 2023
Mosaic Therapeutics, a Cambridge-based oncology therapeutics company, has closed a $28 million Series A funding round. The company has also appointed former Novartis Oncology SVP Brian Gladsden as CEO.
BioMed Realty Becomes New Strategic Partner to Babraham Research Campus Accelerate@Babraham Bio-incubator Programme
10 January 2023
The Babraham Research Campus is delighted to confirm BioMed Realty’s support for its Accelerate@Babraham bio-incubator programme.
Kathryn Chapman relishing challenge to grow Babraham Research Campus
06 January 2023
Dr Kathryn Chapman is relishing the challenges she has taken on as she steps into the new role of director, science and entrepreneurship at Babraham Research Campus.
Qkine raises over £4M to scale manufacturing, R&D and commercial functions
15 December 2022
Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M.
Kalium Health’s investment round sets up success for 2023
01 December 2022
Kalium Health, which aims to transform the way that kidney disease and heart disease is managed, has announced a new phase of growth backed by a new investment round.
Babraham Research Campus Ltd appoints Kathryn Chapman as Director of Science & Entrepreneurship
21 November 2022
Babraham Research Campus Ltd is delighted to announce the appointment of Dr Kathryn Chapman to the newly created role of Director, Science & Entrepreneurship.
Shift Bioscience Vacancy: Computational biologist
14 October 2022
Shift Bioscience are looking to recruit a Computational biologist to join their team.
Cambridge irons out the wrinkles in anti-ageing science arena
25 April 2022
Cambridge is playing a lead role in developing technology designed to rejuvenate skin cells and arrest the march of age-related diseases.
From ‘a metaphorical slap around the face’ to ‘life-saving’ - how life science start-ups view Accelerate@Babraham
04 April 2022
The latest cohort of five life science start-ups to complete the 2021/22 cycle of Accelerate at Babraham may have had the added pressure of a pandemic throughout the five-month programme but all made great strides to develop their business propositions, which in turn promises to change patient outcomes.
Accelerate@Babraham alumni, Shift Bioscience is hiring!
21 February 2022
The longevity biotech company using machine learning to develop therapeutics for safe cellular reprogramming has three open positions.
Qkine earns ISO9001: 2015 certification for protein R&D and manufacture facilities
12 October 2021
Qkine is delighted to achieve ISO9001: 2015 certification, an internationally recognised standard that confirms its commitment to exceptional product quality, customer service and scientific support.
Make an impact - join the MOSAIC team!
05 October 2021
MOSAIC are tackling cancers with substantial unmet need by reinventing target discovery, using large scale data generation, aggregation and analytics platforms Could you use your skills to improve the lives of cancer patients?
Winners of Accelerate@Babraham competition announced
27 September 2021
Five promising early-stage life science ventures are beginning the next steps of their entrepreneurial adventure at one of the most successful locations for life science start-ups in Europe, the Babraham Research Campus, Cambridge.
CC Bio aims to improve health of millions of women and cystic fibrosis patients with microbiome editing technology
24 September 2021
The lives of millions of women around the world could be improved by extraordinary microbiome editing technology pioneered by synthetic biology start-up CC Bio.
Bacteria blitzer CC Bio wins £890k to fast-track personalised cures
27 August 2021
Award-winning synthetic biology start-up CC Bio has raised £890,000 seed funding from Cambridge-based CMS Ventures to accelerate development of its innovative approach to infection treatment and prevention.
Qkine and Enantis sign licensing deal to bring hyperstable FGF2-STAB® to the global stem cell community
29 July 2021
Cambridge University spin-out, Qkine, and Enantis, a biotechnology spin-off company from Masaryk University, have concluded a licensing deal for Qkine to use Enantis’s patented FGF2-STAB® technology globally.
Podcast: BioInnovation Spotlight @ LifeScience ORG
23 July 2021
Daniel Ives, CEO, Shift Biosciences, an Accelerate@Babraham portfolio company talks to Lifescience ORG’s David Kirk in the the latest BioInnovation Spotlight podcast - detailing the motivation behind his research and the age-related conditions it may help.
Kalium Health appoints Kenneth Galbraith as Chair of the Board
13 May 2021
Kalium Health Ltd, which is working to help millions of people living with kidney disease and related conditions to manage their health at home, is pleased to announce the appointment of Kenneth Galbraith as Chair of the Board.
Applications invited for Accelerate@Babraham life science start-up competition
10 May 2021
Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.
The 25 Best Biotech Incubators Hatching Startup Stars in Europe
06 April 2021
Incubators can give biotech startups the boost they need to get off the ground. Accelerate@Babraham has made Labiotech's top 25 biotech incubators across Europe supporting the next generation of life science startups.
Kalium Health announces funding from National Institute for Health Research
23 March 2021
Kalium Health Ltd, which is working to help millions of people living with kidney disease and related conditions to manage their health at home, today announces it has been awarded funding by the National Institute for Health Research (NIHR).
Welsh startup Antiverse raises $2m for antibody discovery toolkit
16 March 2021
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies.
Kidney Research UK confirmed as new strategic partner to the Babraham Research Campus Accelerate@Babraham initiative
15 February 2021
Kidney Research UK joins other high profile partners committed to the continued evolution of the Campus bio-incubator programme.
How Tamsin’s 2020 challenges led to a British Empire Medal in 2021
07 January 2021
There’s a whole industry built around innovation and how to be an innovator, but what they don’t tell you is that innovation often happens almost accidentally – as Dr Tamsin Brown found when her glue ear device was adopted by surgeons at Addenbrooke’s Hospital who couldn’t hear very well through all the PPE they have to wear.
Paediatric HealthTech (HearGlueEar) wins Accelerate@Babraham with AstraZeneca Start-up Pitching Competition to secure £10,000 additional non-dilutive funding from CMS Ventures
26 November 2020
The Babraham Research Campus’ third cohort of Accelerate@Babraham life science start-ups went head-to-head on Wednesday afternoon (Nov 25th); competing for £10,000 additional funding generously donated by CMS Ventures.
An evaluation of the Hear Glue Ear mobile application for children aged 2–8 years old with otitis media with effusion
25 October 2020
Read the full report which evaluates the acceptability and usability of the Hear Glue Ear mobile application to guide families and support speech and language development in children with otitis media with effusion (OME).
Accelerate@Babraham Start-up Programme underway with four new life science start-ups taking part in the five month programme
21 September 2020
The Babraham Research Campus’ third cohort of Accelerate@Babraham life science start-ups came together today for the first day of the 2020/21 programme.
Reflection Therapeutics secures co-funding from Innovate UK for major research programme to fight motor neurone disease through cell therapy
13 August 2020
Reflection Therapeutics, Cambridge-based developer of cell therapy against neuroinflammation, is pleased to announce the start of a major Innovate Smart Grant project co-funded by Innovate UK, the UK’s innovation agency.
Qkine secures £1.5M series A funding from leading life science investors
09 June 2020
Qkine today announced the successful closure of a £1.5M series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team.
Start-ups the rock stars of our generation
04 June 2020
The second life science bio-incubator programme at the Babraham Research Campus ended on a high for its participants as they presented their science and achievements to a distinguished audience.
VisusNano awarded over £225,000 by Innovate UK
03 June 2020
VisusNano, a medtech company developing a biodegradable intraocular lens that can release drugs directly into the eye, has been awarded just over £225,000 by Innovate UK.
Eisai pledges its support for the Babraham Research Campus’ Accelerate@Babraham initiative
27 April 2020
The Babraham Research Campus is delighted to confirm Eisai as the latest high-profile organisation to provide financial and mentoring support for its Accelerate@Babraham initiative.
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology
16 April 2020
MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels.
Two startups share LifeArc ‘Accelerate’ Award
18 March 2020
Introduced by the Babraham Research Campus in 2018, the Accelerate@Babraham initiative supports ambitious early stage life science ventures within the active Babraham Research Campus community.
The end of this year’s Accelerate@Babraham programme doesn’t necessarily mean the end of the journey at the Babraham Research Campus for the winning start-ups
10 March 2020
After spending five-months on Campus the five winning StartUP@Babraham competition start-ups have come to the end of the programme. But for some, their journey at the Babraham Research Campus has only just begun.
LifeArc ‘Accelerate@Babraham Award’ for most progressed venture awarded to CC Bio and Reflection Therapeutics
05 March 2020
Introduced by the Babraham Research Campus in 2018, the Accelerate@Babraham initiative supports ambitious early stage life science ventures within the active Babraham Research Campus community.
LifeArc ‘Accelerate@Babraham Award’ will give one early-stage life science venture additional cash boost
06 January 2020
Sponsors of the Babraham Research Campus Accelerate@Babraham initiative, LifeArc, has announced the extension of its support, by releasing an additional £10,000 in the form of an award for the most progressed venture.
Cambridge biotech luminaries deliver masterclass on hiring and investment
22 November 2019
Our winning Accelerate@Babraham start-ups benefit from the experience of two of the most prominent biotech names in the Cambridge life science cluster - Dr Jane Osbourn and Dr Andy Richards.
The Babraham Research Campus accelerator programme attracts further sponsorship to support early-stage science ventures
11 November 2019
With the second wave of its ‘Accelerate@Babraham’ life sciences bio-incubator programme well underway, the Babraham Research Campus has confirmed additional financial and mentoring support for the initiative from Mundipharma.
Induction Day with Cambridge Life-Science Cluster Vanguards for Accelerate@Babraham 2019 Winners
04 October 2019
The Babraham Research Campus has welcomed the second group of start-ups to its Accelerate@Babraham competition programme with a day of networking and a stellar cast of guest speakers.
Accelerate@Babraham attracts additional sponsorship to boost innovation in Cambridge life science cluster
23 September 2019
LifeArc joins AstraZeneca in providing funding towards the continued development of the Babraham Research Campus’ Accelerate@Babraham initiative.
An Interview With Dr. Daniel Ives of Shift Bioscience
09 August 2019
Shift Bioscience is a company aiming to solve the problem of mitochondrial dysfunction, one of the hallmarks of aging, by repairing the aging mitochondria in our cells so that they work as if they were younger.
Qkine secures additional £550K funding
03 June 2019
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio
Patients suggestion leads to new British company developing the world’s first ‘home use’ blood potassium test kit
26 June 2019
A fast, accurate and low-cost test for blood potassium levels, which can be used at home and has the potential to improve the safety, health and lifestyle of tens of millions of people worldwide, is being developed by Kalium Diagnostics.
High-speed drama for Accelerate@Babraham pitches
28 May 2019
The second Accelerate@Babraham start-up competition final at the Babraham Research Campus proved even more full-throttle than the first.
Accelerate@Babraham Start-up Competition 2019: Winners Announced
21 May 2019
Five science start-ups have been awarded £10k, access to the Babraham Research Campus bio-incubator facilities, Accelerate@Babraham, and an extended programme of mentoring and support.
Babraham Research Campus ready for pitching bonanza
13 May 2019
The Campus is going to be busy on Wednesday (May 15), with the one-day Babraham Investor Conference (BIC) immediately followed by the Accelerate@Babraham pitches, which gives five organisations the chance to work at Babraham for five months.
Presentation Day showcases success of Accelerate@Babraham Start-up Competition
23 December 2018
The first ever life science bio-incubator programme competition at the Babraham Research Campus, Accelerate@Babraham, has ended on a high for the competition winners with the promise of ongoing mentoring and an invitation to present at the renowned Babraham Investor Conference in 2019.
Accelerate@Babraham intake learns how to walk through walls
04 October 2018
A memorable induction for the first-ever Accelerate@Babraham competition winners cohort included masterclasses from two of Cambridge’s most spectacularly successful entrepreneurs and investors, Andy Richards and Jonathan Milner.
Accelerate@Babraham attracts additional support from Taylor Vinters and Silicon Valley Bank
10 September 2018
International law firm and technology focused banking group confirm support for Accelerate@Babraham’s inaugural programme.
Accelerate@Babraham Start-up Competition: Winners announced
13 July 2018
Five science start-ups have been awarded £20k and access to the Babraham Research Campus bio-incubator facilities, Accelerate@Babraham.
The Babraham Research Campus launches start-up competition for the chance to access its life science bio-incubator, Accelerate@babraham
29 May 2018
Life science start-ups are invited to apply for one of up to five prizes that include a cash prize and access to the Babraham Research Campus bio-incubator facilities and much more...